Pfizer becomes sixth vaccine to be approved by Thailand’s FDA

schedule
2021-06-24 | 14:29h
update
2026-11-19 | 08:33h
person
lasvegasnews.media
domain
lasvegasnews.media


Vials labelled “COVID-19 Coronavirus Vaccine” and a syringe are seen in front of the Pfizer logo in this illustration taken February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo

Pfizer-BioNTech has become the sixth vaccine to be approved by Thailand’s Food and Drug Administration (TFDA), for emergency use in the country, said TFDA Secretary-General Paisal Dunkhum today (Thursday).

Pfizer’s “Comirnaty” vaccine is an mRNA vaccine which encodes a mutated form of the spike protein found on the surface of the SARS-CoV-2 virus, which causes COVID-19, producing an immune response. It is recommended for people aged 12 and over and is administered in two doses, with a dosing interval of three weeks.

Advertisement

The five other vaccines approved by the TFDA are Sinovac and Sinopharm from China, Moderna and Johnson & Johnson from the United States and the British-Swedish Oxford-AstraZeneca.

According to Public Health Minister Anutin Charnvirakul, 20 million doses of Pfizer have been ordered, with deliveries expected in the last quarter of this year.

Thailand plans to administer the vaccine to youths aged 12-18.



Source link

Advertisement

Imprint
Responsible for the content:
lasvegasnews.media
Privacy & Terms of Use:
lasvegasnews.media
Mobile website via:
WordPress AMP Plugin
Last AMPHTML update:
19.11.2026 - 08:33:28
Privacy-Data & cookie usage: